BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17196131)

  • 1. [Effect of HCV NS5A on STAT1 phosphorylation and nuclear translocation induced by IFN alpha-2b].
    Cao J; Zhou Y; Gong GZ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):894-7. PubMed ID: 17196131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus non-structural 5A abrogates signal transducer and activator of transcription-1 nuclear translocation induced by IFN-alpha through dephosphorylation.
    Gong GZ; Cao J; Jiang YF; Zhou Y; Liu B
    World J Gastroenterol; 2007 Aug; 13(30):4080-4. PubMed ID: 17696225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines.
    Lan KH; Lan KL; Lee WP; Sheu ML; Chen MY; Lee YL; Yen SH; Chang FY; Lee SD
    J Hepatol; 2007 May; 46(5):759-67. PubMed ID: 17275127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
    Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
    Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.
    Poat B; Hazari S; Chandra PK; Gunduz F; Balart LA; Alvarez X; Dash S
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20949125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs.
    Melén K; Fagerlund R; Nyqvist M; Keskinen P; Julkunen I
    J Med Virol; 2004 Aug; 73(4):536-47. PubMed ID: 15221897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment.
    Kang SM; Won SJ; Lee GH; Lim YS; Hwang SB
    FEBS Lett; 2010 Sep; 584(18):4069-76. PubMed ID: 20804757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.
    Parvaiz F; Manzoor S; Iqbal J; Sarkar-Dutta M; Imran M; Waris G
    World J Gastroenterol; 2015 Nov; 21(43):12361-9. PubMed ID: 26604643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
    Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
    J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.
    Kumthip K; Chusri P; Jilg N; Zhao L; Fusco DN; Zhao H; Goto K; Cheng D; Schaefer EA; Zhang L; Pantip C; Thongsawat S; O'Brien A; Peng LF; Maneekarn N; Chung RT; Lin W
    J Virol; 2012 Aug; 86(16):8581-91. PubMed ID: 22674974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1.
    Efstathiou C; Zhang Y; Kandwal S; Fayne D; Molloy EJ; Stevenson NJ
    Front Immunol; 2024; 15():1395809. PubMed ID: 38938568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanism of HCV NS5A on p53's inhibition of AFP expression in hepatocellular carcinoma cells].
    Gong GZ; Jiang YF; He Y; Lai LY; Xu Y; Su XS
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):505-8. PubMed ID: 16042885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.
    He CL; Liu M; Tan ZX; Hu YJ; Zhang QY; Kuang XM; Kong WL; Mao Q
    World J Gastroenterol; 2018 Jan; 24(2):226-236. PubMed ID: 29375208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.
    Polyak SJ; Khabar KS; Paschal DM; Ezelle HJ; Duverlie G; Barber GN; Levy DE; Mukaida N; Gretch DR
    J Virol; 2001 Jul; 75(13):6095-106. PubMed ID: 11390611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HCV NS5A protein down-regulates hepcidin gene expression and increases hepatic intracellular iron storage].
    Liu YZ; Xiao XQ; Cheng D; Jiang YF; Gong GZ
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):894-7. PubMed ID: 22525500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway.
    Matsumoto A; Ichikawa T; Nakao K; Miyaaki H; Hirano K; Fujimito M; Akiyama M; Miuma S; Ozawa E; Shibata H; Takeshita S; Yamasaki H; Ikeda M; Kato N; Eguchi K
    J Gastroenterol; 2009; 44(8):856-63. PubMed ID: 19436942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.